Head of U.S. medical research agency to step down by year-end
Reuters
Published Oct 05, 2021 08:20AM ET
Updated Oct 05, 2021 06:07PM ET
(Reuters) -Francis Collins, director of U.S. National Institutes of Health (NIH), said on Tuesday https://www.nih.gov/news-events/news-releases/francis-collins-step-down-director-national-institutes-health he would step down from his role by the end of the year, after leading the medical research agency for 12 years.
Collins, a genetics pioneer, was appointed as the head of NIH in 2009 by then-President Barack Obama, and he went on to serve the agency under three presidents.
"Twelve years is a long time," Collins, 71, said in an interview with Fox News Channel. "No other NIH director has stayed in this job even close to that. ... It's time for new leadership, new vision."
"NIH is in a good place right now," said Collins, who has been one of the leading figures in the U.S. response to the COVID-19 pandemic.
He said he was not worried that the fight against the pandemic would lose momentum by his stepping down.
His decision gives President Joe Biden ample time to find a new director, who would have to be confirmed by the U.S. Senate, Collins said.
Collins joined the NIH in 1993 and helped lead work that identified genes associated with Type 2 diabetes.
He worked at NIH until May 2008 then left to pursue writing projects, before being appointed director. Then- President Donald Trump in 2017 and Biden in 2021 asked him to continue in the role.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.